NCT02163707View on ClinicalTrials.gov

UW Psilocybin Pharmacokinetics Study

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy
Interventions
DRUG

Psilocybin

Dose 1: 0.3 mg/kg (approximately 20mg/70kg) Dose 2: 0.45 mg/kg (approximately 30 mg/70 kg) Dose 3: 0.6 mg/kg (approximately 40 mg/70 kg)

Trial Locations (1)

53705

University of Wisconsin, School of Pharmacy, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT02163707 - UW Psilocybin Pharmacokinetics Study | Biotech Hunter | Biotech Hunter